SEATTLE (AP) — SEATTLE (AP) — Adaptive Biotechnologies Corp. (ADPT) on Tuesday reported a loss of $20 million in its first quarter.
The Seattle-based company said it had a loss of 13 cents per share.
The results beat Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 16 cents per share.
The life-sciences research company posted revenue of $70.9 million in the period, also exceeding Street forecasts. Five analysts surveyed by Zacks expected $61.8 million.
Adaptive Biotechnologies shares have dropped 15% since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $13.80, a rise of 38% in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ADPT at https://www.zacks.com/ap/ADPT
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
